University of Wisconsin-Madison Population Health Institute, Madison, Wisconsin.
Department of Public Health, Robbins College of Health and Human Sciences, Baylor University, Waco, Texas.
J Stud Alcohol Drugs. 2021 Nov;82(6):700-709. doi: 10.15288/jsad.2021.82.700.
Screening, Brief Intervention and Referral to Treatment (SBIRT) programs have been effective for moderate reductions of alcohol use among participants in universal settings. However, there has been limited evidence of effectiveness in referring individuals to specialty care, and the literature now often refers to screening and brief intervention (SBI). This study examines documentation of substance use disorder (SUD) diagnoses in a low-income Medicaid population to evaluate the effect of universal SBIRT on healthcare system recognition of SUDs, a first step to obtaining a referral to treatment (RT) for individuals with SUDs.
SBI patient data from Wisconsin's Initiative to Promote Healthy Lifestyles (WIPHL) were linked to Wisconsin Medicaid claims data. A comparison group of Medicaid beneficiaries was identified from a matched sample of non-SBIRT clinics (total study = 14,856). Hierarchical generalized linear modeling was used to assess rates of SUD diagnosis in the 12 months following receipt of SBIRT in WIPHL clinics compared with rates in non-SBIRT clinics. Analysis controlled for clinic, individual patient's health status, demographics, and baseline substance use diagnoses.
SBIRT was associated with greater odds of being diagnosed with (DSM-IV), alcohol abuse or dependence as well as drug abuse or dependence over the 12 months subsequent to receipt of the screen. The overall diagnostic rate for any DSM-IV substance abuse or dependence was 9.9% at baseline and 12.2% during the follow-up year. SBIRT patients had 42% ( = .003) greater odds of being diagnosed with a substance use disorder within 12 months relative to comparison clinic patients. However, there were very few claims for specialty SUD services.
The presence of SBIRT in a primary care clinic appears to increase the awareness and recognition of patients with SUDs and a greater willingness of healthcare providers to diagnose patients with an alcohol or drug use disorder on Medicaid claims. Further research is needed to determine if this increase in diagnosis reflects integrated care for SUDs or if it leads to improved access to specialty care, in which case abandonment of the RT component of SBIRT may be premature.
在普遍环境中,筛查、简短干预和转介治疗(SBIRT)计划已被证明可有效减少参与者的饮酒量。然而,将个人转介到专业护理的有效性证据有限,而且现在文献通常指的是筛查和简短干预(SBI)。本研究通过考察在低收入医疗补助人群中物质使用障碍(SUD)诊断的记录,评估普遍 SBIRT 对医疗保健系统识别 SUD 的影响,这是为 SUD 患者获得治疗转介(RT)的第一步。
将威斯康星州促进健康生活方式倡议(WIPHL)的 SBI 患者数据与威斯康星州医疗补助索赔数据相关联。从非 SBIRT 诊所的匹配样本中确定了一个 Medicaid 受益人的对照组(总研究=14856)。使用分层广义线性模型来评估在 WIPHL 诊所接受 SBIRT 后的 12 个月内 SUD 诊断率与非 SBIRT 诊所的诊断率。分析控制了诊所、个体患者的健康状况、人口统计学特征和基线物质使用诊断。
SBIRT 与在接受筛查后的 12 个月内被诊断为DSM-IV 酒精滥用或依赖以及药物滥用或依赖的可能性更大相关。在基线时任何 DSM-IV 物质滥用或依赖的总体诊断率为 9.9%,在随访年为 12.2%。SBIRT 患者在 12 个月内被诊断为物质使用障碍的可能性比对照组患者高 42%(=0.003)。然而,只有极少数人提出了特殊的 SUD 服务要求。
初级保健诊所中存在 SBIRT 似乎会增加对 SUD 患者的认识和识别,并增加医疗保健提供者在医疗补助索赔中诊断患有酒精或药物使用障碍的意愿。需要进一步研究以确定这种诊断增加是否反映了对 SUD 的综合护理,或者是否导致对专业护理的更好获得,如果是这样,那么提前放弃 SBIRT 的 RT 部分可能还为时过早。